280 related articles for article (PubMed ID: 12696076)
1. D-dimer and its relationship to fibrinogen/fibrin degradation products (FDPs) in disorders associated with activation of coagulation or fibrinolytic systems.
Moresco RN; Vargas LC; Voegeli CF; Santos RC
J Clin Lab Anal; 2003; 17(3):77-9. PubMed ID: 12696076
[TBL] [Abstract][Full Text] [Related]
2. A comparative evaluation of assays for markers of activated coagulation and/or fibrinolysis: thrombin-antithrombin complex, D-dimer and fibrinogen/fibrin fragment E antigen.
Boisclair MD; Lane DA; Wilde JT; Ireland H; Preston FE; Ofosu FA
Br J Haematol; 1990 Apr; 74(4):471-9. PubMed ID: 2189490
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of latex agglutination kits for detection of fibrin(ogen) degradation products and D-dimer in healthy horses and horses with severe colic.
Stokol T; Erb HN; De Wilde L; Tornquist SJ; Brooks M
Vet Clin Pathol; 2005 Dec; 34(4):375-82. PubMed ID: 16270263
[TBL] [Abstract][Full Text] [Related]
4. Incidence and possible reasons for discordant results between positive FDP and negative D-dimer latex assays in clinical specimens.
Song KS; Kim YA; Kim HK; Park Q
Yonsei Med J; 1999 Apr; 40(2):107-11. PubMed ID: 10333712
[TBL] [Abstract][Full Text] [Related]
5. Plasma D-dimer levels and their relationship to serum fibrinogen/fibrin degradation products in hypercoagulable states.
Wilde JT; Kitchen S; Kinsey S; Greaves M; Preston FE
Br J Haematol; 1989 Jan; 71(1):65-70. PubMed ID: 2917130
[TBL] [Abstract][Full Text] [Related]
6. Measurement of plasma fibrin D-dimer levels with the use of a monoclonal antibody coupled to latex beads.
Greenberg CS; Devine DV; McCrae KM
Am J Clin Pathol; 1987 Jan; 87(1):94-100. PubMed ID: 3541576
[TBL] [Abstract][Full Text] [Related]
7. Assessment of hypercoagulable states by measurement of activation fragments and peptides.
Boisclair MD; Ireland H; Lane DA
Blood Rev; 1990 Mar; 4(1):25-40. PubMed ID: 2182146
[TBL] [Abstract][Full Text] [Related]
8. Fibrinogen degradation products in patients with the Quebec platelet disorder.
Hayward CP; Welch B; Bouchard M; Zheng S; Rivard GE
Br J Haematol; 1997 May; 97(2):497-503. PubMed ID: 9163623
[TBL] [Abstract][Full Text] [Related]
9. Validity of enzyme-linked immunosorbent assays of cross-linked fibrin degradation products as a measure of clot lysis.
Eisenberg PR; Jaffe AS; Stump DC; Collen D; Bovill EG
Circulation; 1990 Oct; 82(4):1159-68. PubMed ID: 2119264
[TBL] [Abstract][Full Text] [Related]
10. Association between plasma levels of D-dimer and fibrinogen/fibrin degradation products (FDP) for exclusion of thromboembolic disorders.
Moresco RN; Júnior RH; Cláudio Rosa Vargas L; Mariano da Rocha Silla L
J Thromb Thrombolysis; 2006 Apr; 21(2):199-202. PubMed ID: 16622618
[TBL] [Abstract][Full Text] [Related]
11. The D-dimer assay.
Johnson ED; Schell JC; Rodgers GM
Am J Hematol; 2019 Jul; 94(7):833-839. PubMed ID: 30945756
[TBL] [Abstract][Full Text] [Related]
12. Estimation of the levels of D-dimer by use of an alternative method based in the reaction time of fibrinogen/fibrin degradation products assay.
Moresco RN; Vargas LC; Silla L
J Thromb Thrombolysis; 2007 Aug; 24(1):73-6. PubMed ID: 17160549
[TBL] [Abstract][Full Text] [Related]
13. Widely Used Types and Clinical Applications of D-Dimer Assay.
Riley RS; Gilbert AR; Dalton JB; Pai S; McPherson RA
Lab Med; 2016 May; 47(2):90-102. PubMed ID: 27016528
[TBL] [Abstract][Full Text] [Related]
14. Diagnosis of disseminated intravascular coagulation. Role of D-dimer.
Carr JM; McKinney M; McDonagh J
Am J Clin Pathol; 1989 Mar; 91(3):280-7. PubMed ID: 2646905
[TBL] [Abstract][Full Text] [Related]
15. Fibrin D-dimer in thrombogenic disorders.
Matsuo T; Kobayashi H; Kario K; Suzuki S
Semin Thromb Hemost; 2000; 26(1):101-7. PubMed ID: 10805290
[TBL] [Abstract][Full Text] [Related]
16. [Clinical significance of cross linked fibrin degradation products in thrombotic disorders].
Koyama T; Oura Y; Higuchi M; Kakishita E; Nagai K
Rinsho Ketsueki; 1989 May; 30(5):659-62. PubMed ID: 2677436
[TBL] [Abstract][Full Text] [Related]
17. [Clinical use of D-dimer testing].
Lachâtre F; Gothot A
Rev Med Liege; 2007 Jan; 62(1):29-35. PubMed ID: 17343127
[TBL] [Abstract][Full Text] [Related]
18. D-dimer concentrations in healthy dogs and dogs with disseminated intravascular coagulation.
Stokol T; Brooks MB; Erb HN; Mauldin GE
Am J Vet Res; 2000 Apr; 61(4):393-8. PubMed ID: 10772103
[TBL] [Abstract][Full Text] [Related]
19. Performance of the automated and rapid STA Liatest D-dimer on the STA-R analyzer.
Waser G; Kathriner S; Wuillemin WA
Thromb Res; 2005; 116(2):165-70. PubMed ID: 15907532
[TBL] [Abstract][Full Text] [Related]
20. D-dimer, other markers of haemostasis activation and soluble adhesion molecules in patients with different clinical probabilities of deep vein thrombosis.
Bozic M; Blinc A; Stegnar M
Thromb Res; 2002 Nov; 108(2-3):107-14. PubMed ID: 12590945
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
